Increase of ceramide monohexoside and dipalmitoyl glycerophospholipids in the brain of Zellweger syndrome

Neuroscience Letters

Volumn 417, Issue 2, 2007, Pages 165-170

  Saitoh, Makiko ^a   Sakakihara, Yoichi ^b   Mizuguchi, Masashi ^a   Itoh, Masayuki ^c   Takashima, Sachio ^d   Iwamori, Masao ^e   Kamoshita, Shigehiko ^f   Igarashi, Takashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b OCHANOMIZU UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^d INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^e KINKI UNIVERSITY   (Japan)

^f San ikukai Hospital   (Japan)

Author keywords

Ceramide monohexoside; Cholesterol; Dipalmitoyl glycerophospholipid; Peroxisome; Zellweger syndrome

Indexed keywords

CERAMIDE DERIVATIVE; CHOLESTEROL ESTER; DIPALMITOYLPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE;

ARTICLE; BRAIN TISSUE; GRAY MATTER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOHISTOCHEMISTRY; LIPID COMPOSITION; PATHOGENESIS; PRIORITY JOURNAL; WHITE MATTER; ZELLWEGER SYNDROME;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; CEREBRAL CORTEX; CEREBROSIDES; HUMANS; INFANT; LIPID METABOLISM; MALE; MEMBRANE LIPIDS; NERVE DEGENERATION; NERVE FIBERS, MYELINATED; NEURONS; PHOSPHATIDYLSERINES; UP-REGULATION; ZELLWEGER SYNDROME;

EID: 34047261628     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.01.083     Document Type: Article

References (22)

1. Blank M.L., Robinson M., Fizgerald V., and Snyder F. Novel quantitative method for determination of molecular species of phospholipids and diglycerides. J. Chromatogr. 298 (1984) 473-482
2. Farooqui A., Horrocks L.A., and Farooqui T. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem. Phys. Lipids 106 (2000) 1-29
3. Gould S.J., Raymond G.V., and Valle D. The peroxisome biogenesis disorders. In: Scriver B.V., Beaudet S., Valle D., and Sly O. (Eds). The Metabolic and Molecular Basis of Inherited Disease (2001), MacGraw-Hill, New York 3181-3217
4. Iwamori M., Hirota K., Utsuki T., Momoeda K., Ono K., Tsuchida Y., Okumura K., and Hanaoka K. Sensitive method for the determination of pulmonary surfactant phospholipid/sphingomyelin ratio in human amniotic fluids for the diagnosis of respiratory distress syndrome by thin-layer chromatography-immunostaining. Anal. Biochem. 238 (1996) 29-33
5. Lou H.C., Holmer G.K., Reske-Nielsen E., and Vagn-Hansen P. Lipid composition in gray and white matter of the brain in Menkes' disease. J. Neurochem. 22 (1974) 377-381
6. Moser A.B., Kreiter N., Bezman L., Lu S., Raymond G.V., Naidu S., and Moser H.M. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann. Neurol. 45 (1999) 100-110
7. Nagura M., Saito M., Iwamori M., Sakakihara Y., and Igarashi T. Alterations of FFA metabolism and membrane fluidity in peroxisome-defective mutant ZP102 cells. Lipids 39 (2004) 43-50
8. O'Brien J.S., and Sampson E.L. Lipid composition of the normal human brain: gray matter, white matter, and myelin. J. Lipid Res. 6 (1965) 537-544
9. Otton R., and Curi R. Toxicity of a mixture of fatty acids on human blood lymphocytes and leukemia cell lines. Toxicol. In Vitro 19 (2005) 749-755
10. Powers J.M., Tummons R.C., Caviness Jr. V.S., Moser A.B., and Moser H.W. Structural and chemical alterations in the cerebral maldevelopment of fetal cerebro-hepato-renal (Zellweger) syndrome. J. Neuropathol. Exp. Neurol. 48 (1989) 270-289
11. Saito M., Fukushima Y., Tatsumi K., Lin B., Fujiki Y., Iwamori M., Igarashi T., and Sakakihara Y. Molecular cloning of Chinese hamster ceramide glucosyltransferase and its enhanced expression in peroxisome-defective mutant Z65 cells. Arch. Biochem. Biophys. 403 (2002) 171-178
12. Saito M., Iwamori M., Lin B., Oka A., Fujiki Y., Shimozawa N., Kamoshita S., Yanagisawa M., and Sakakihara Y. Accumulation of glycolipids in mutant Chinese hamster ovary cells (Z65) with defective peroxisomal assembly and comparison of the metabolic rate of glycosphingolipids between Z65 cells and wild-type CHO-K1 cells. Biochim. Biophys. Acta 1438 (1999) 55-62
13. Schroeder F. Role of membrane lipid asymmetry in aging. Neurobiol. Aging 5 (1984) 323-333
14. Shinitzky M., Herron D.S., and Samuel D. Restoration of membrane fluidity and serotonin receptors in the aged mouse brain. In: Samuel D., Algeri S., and Gershon V.E. (Eds). Aging of the Brain (1983), Ravan Press, New York 329-336
15. 1-gangliosidosis (generalized gangliosidosis). J. Neuropathol. Exp. Neurol. 28 (1969) 25-73
16. Svennerholm L., Rynmark B.M., Vilbergsson G., Fredman P., Gottfries J., Mansson J.E., and Percy A. Gangliosides in human fetal brain. J. Neurochem. 56 (1991) 1763-1768
17. Tatsumi K., Saito M., Lin B., Iwamori M., Ichiseki H., Shimozawa N., Kamoshita S., Igarashi T., and Sakakihara Y. Enhanced expression of a-series gangliosides in fibroblasts of patients with peroxisome biogenesis disorders. Biochim. Biophys. Acta 1535 (2001) 285-293
18. Tettamanti G., and Riboni L. Gangliosides and modulation of the function of neural cells. Adv. Lipid Res. 25 (1993) 235-267
19. Tone O., Miller J.C., Bell J.M., and Rapoport S.I. Regional cerebral palmitate incorporation following transient bilateral carotid occlusion in awake gerbils. Stroke 18 (1987) 1120-1127
20. Uemura K., Sugiyama E., and Taketomi T. Effects of an inhibitor of glucosylceramide synthase on glycosphingolipid synthesis and neurite outgrowth in murine neuroblastoma cell lines. J. Biochem. 110 (1991) 96-102
21. Volpe J.J., and Adams D.D. Cerebro-hepato-renal syndrome of Zellweger: an inherited disorder of neuronal migration. Acta Neuropathol. 20 (1972) 175-198
22. Wakabayashi S., Freed L.M., Bell J.M., and Rapoport S.I. In vivo cerebral incorporation of radiolabeled fatty acid after acute unilateral orbital enucleation in adult hooded Long Evans rats. J. Cereb. Blood Flow Metab. 14 (1994) 312-323